Travere Therapeutics Inc (TVTX)
Cost of Revenue
$33.08M
TTM · Period ending: · USD
TVTX Cost of Revenue
Latest reported$33.08Mperiod ending
Latest reported$33.08Mperiod ending
TVTX TTM Cost of Revenue ($0.00 → $33.08M)
TTM cost of revenue
High-resolution chart · PNG
TVTX cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 33,078,000 | |
| 32,425,000 | |
| 10,338,000 | |
| 10,338,000 | |
| 10,379,000 | |
| 21,264,000 | |
| 18,089,000 | |
| 31,952,000 | |
| 31,615,000 | |
| 20,661,000 | |
| 24,282,000 | |
| 9,594,000 | |
| 15,571,000 | |
| 16,170,000 | |
| 13,183,000 | |
| 13,351,000 | |
| 7,677,000 | |
| 7,277,000 | |
| 6,784,000 | |
| 6,960,000 | |
| 6,557,000 | |
| 6,400,000 | |
| 6,125,000 | |
| 11,068,000 | |
| 11,392,000 | |
| 10,877,000 | |
| 10,524,000 | |
| 5,112,000 | |
| 4,732,000 | |
| 4,931,000 | |
| 5,527,000 | |
| 5,098,000 | |
| 4,890,000 | |
| 4,509,000 | |
| 3,605,000 | |
| 3,634,000 | |
| 4,282,000 | |
| 4,506,000 | |
| 4,554,000 | |
| 4,112,000 | |
| 3,052,000 | |
| 2,668,000 | |
| 2,185,447 | |
| 1,762,155 | |
| 1,446,566 | |
| 2,016,961 | |
| 1,743,414 | |
| 1,505,706 | |
| 1,308,295 | |
| 100,900 | |
| 100,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |